New Capability at Pharmidex: Luminex xMAP INTELLIFLEX™
February 9, 2026

We’re excited to announce that Pharmidex has expanded its analytical capabilities with the addition of the xMAP INTELLIFLEX™ system, a powerful, high-performance platform for multiplex biomarker analysis.


This advanced technology enables the simultaneous measurement of multiple analytes from minimal sample volumes, delivering exceptional sensitivity, accuracy and reproducibility. It is ideally suited for complex biological matrices and supports a wide range of applications, from biomarker discovery to translational and preclinical studies. 



Our INTELLIFLEX™ supports dual reporter channels to collect more data per sample.


🔬 What this means for our partners and the wider scientific community:

• Faster, data-rich insights from fewer samples

• Enhanced assay flexibility and scalability

• Improved data quality to support confident decision-making

• Greater efficiency across drug discovery and development programmes


This investment strengthens Pharmidex’s commitment to scientific excellence, allowing us to deliver even more robust, innovative and reliable services to pharma, biotech, CROs and academic collaborators.


We look forward to putting this new capability to work in support of better science and better medicines.

#Pharmidex #Innovation #Biomarkers #Multiplexing #DrugDevelopment #LifeSciences #AnalyticalExcellence

Pharmidex team members runs the St Albans Summer Solstice 10K!

June 23, 2026
🏃‍♂️☀️ Congratulations to our Pharmidex team members who took part in the St Albans Summer Solstice 10K #BeatTheSunset ! It was great to see colleagues enjoying a fantastic summer evening while supporting their physical and mental wellbeing. At Pharmidex , we believe health extends beyond the laboratory and activities like these are a great way to stay active, connect with colleagues and have fun. Well done to everyone who took part and represented Pharmidex so positively!

Thanks to our interns from City St George’s, University of London

June 19, 2026
A big thank you to our interns from City St George’s, University of London and heir fantastic contribution to Pharmidex over the past few months. They have supported scientific projects across the business, developed valuable technical skills and gained hands-on experience within a CRO environment. Their contribution has extended beyond the laboratory, helping with our website, marketing materials, conference preparation and business development activities. Science drives success, but communicating that science effectively is just as important. Our interns have helped us do both. Thank you for your hard work, enthusiasm, and dedication. We wish you every success in the next stage of your careers.

Pharmidex at the "Creative Disruption Forum: Modern Drug Discovery in Cambridge."

June 17, 2026
On 18 June, our COO, Ash Alavijeh , will join an industry panel discussing: "What are the advantages and disadvantages of working with UK-based Discovery CROs?" The session will explore the value of UK CROs in supporting innovation, protecting IP, accessing scientific expertise and accelerating drug discovery programmes. 📅 18 June 2025 📍 Cambridge 🕒 Panel Session: 12:20–12:45 We look forward to connecting with colleagues, collaborators, and innovators from across the life sciences community.
More Posts